“President Donald Trump announced Thursday that brand-name or patented pharmaceutical products will be subject to a 100% tariff starting October 1 – unless the drugmaker is building a manufacturing plant in the US,” CNN reports.
“Trump has been promising for months to levy tariffs on pharmaceutical imports, which avoided tariffs during his first term. The president sees tariffs as a way to pressure drug manufacturers to ramp up production in the US and to strengthen the supply chain for essential medicines.”
